DMG Mori (6141) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Consolidated order intake reached JPY 155.4 bn, up 28.8% YoY, marking a quarterly record high, with strong demand across all regions and industries such as aircraft, defense, energy, and data-processing.
Sales revenue for Q1 FY2026 was JPY 135.5 bn (+18.9% YoY), EBITDA JPY 12.5 bn (+25.9% YoY), EBIT JPY 3.4 bn (+88.8% YoY), and EAT JPY 1.5 bn, a significant turnaround from the prior year loss.
Upward revision of FY2026 guidance: order intake to JPY 580.0 bn, revenue to JPY 565.0 bn, EBITDA to JPY 65.0 bn, EBIT to JPY 28.0 bn, and EAT to JPY 15.0 bn.
Initiatives included opening a new training center in Germany and establishing a research center with the University of Tokyo to foster next-generation manufacturing talent.
Recognized as an A List company for climate change and water security by CDP.
Financial highlights
EBITDA margin improved to 9.2% (from 8.7% YoY); EBIT margin rose to 2.5% (from 1.6% YoY).
Machine order backlog at end of March 2026 was JPY 266.0 bn, up from JPY 240.0 bn at end of December 2025.
Order intake for MRO, spare parts, and engineering grew 18.3% YoY to JPY 35.7 bn.
Basic earnings per share for Q1 2026 was JPY 6.65, compared to a loss of JPY 1.90 in Q1 2025.
Total assets at March 31, 2026 were JPY 877.7 bn, with total equity at JPY 335.8 bn.
Outlook and guidance
Full-year forecasts revised upward on strong 1Q performance and expected price revisions from April to further improve margins.
FY2026 sales revenue forecast revised to JPY 565.0 bn (+9.7% YoY), operating profit to JPY 28.0 bn (+47.6% YoY), and profit attributable to owners of the parent to JPY 15.0 bn (-37.6% YoY due to prior year one-time gains).
Exchange rates assumed: JPY 150/USD and JPY 180/EUR.
Dividend per share maintained at JPY 105.
Latest events from DMG Mori
- FY2025 saw order and profit recovery, but FY2026 profit is set to drop sharply with stable dividends.6141
Q4 202510 Feb 2026 - Order intake steady, sales and EBIT down, net profit rebounded on insurance proceeds.6141
Q3 202530 Oct 2025 - Order intake and average order price rose, but sales and profits declined sharply year-over-year.6141
Q2 20251 Aug 2025 - Net profit collapsed on Russian exit, prompting lower full-year guidance despite stable sales.6141
Q3 202413 Jun 2025 - Upward order revision and margin gains signal strong growth despite one-time Russian loss.6141
Q2 202413 Jun 2025 - Profits fell sharply in FY2024, but automation and new initiatives drive future growth.6141
Q4 20249 Jun 2025 - Profit and revenue declined, but order intake and sustainability efforts support recovery.6141
Q1 20259 Jun 2025